000 01695 a2200493 4500
005 20250515132918.0
264 0 _c20081204
008 200812s 0 0 eng d
022 _a1365-2362
024 7 _a10.1111/j.1365-2362.2008.01982.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWappl, M
245 0 0 _aDasatinib inhibits progenitor cell proliferation from polycythaemia vera.
_h[electronic resource]
260 _bEuropean journal of clinical investigation
_cAug 2008
300 _a578-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDasatinib
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aErythroid Precursor Cells
_xpathology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aJanus Kinase 2
_xantagonists & inhibitors
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyeloid Progenitor Cells
_xpathology
650 0 4 _aPolycythemia Vera
_xgenetics
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aThiazoles
_xpharmacology
700 1 _aJaeger, E
700 1 _aStreubel, B
700 1 _aGisslinger, H
700 1 _aSchwarzinger, I
700 1 _aValent, P
700 1 _aOehler, L
773 0 _tEuropean journal of clinical investigation
_gvol. 38
_gno. 8
_gp. 578-84
856 4 0 _uhttps://doi.org/10.1111/j.1365-2362.2008.01982.x
_zAvailable from publisher's website
999 _c18189911
_d18189911